GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.

Wanner IB, Halford J, Lopez J, Shen S, Chen Y, Zhao H, Salas C, Loo RO, Robicsek S, Ellingson BM, Gornbein J, Van Meter TE, Shaw G, Loo JA, Vespa PM

Open source

DOI: 10.1186/s40478-026-02240-y
Published: 2026 Apr 24
Container: Acta neuropathologica communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40478-026-02240-y,
  title = {GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.},
  author = {Wanner IB and Halford J and Lopez J and Shen S and Chen Y and Zhao H and Salas C and Loo RO and Robicsek S and Ellingson BM and Gornbein J and Van Meter TE and Shaw G and Loo JA and Vespa PM},
  year = {2026},
  journal = {Acta neuropathologica communications},
  doi = {10.1186/s40478-026-02240-y},
  url = {https://doi.org/10.1186/s40478-026-02240-y}
}

RIS

TY  - JOUR
TI  - GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.
AU  - Wanner IB
AU  - Halford J
AU  - Lopez J
AU  - Shen S
AU  - Chen Y
AU  - Zhao H
AU  - Salas C
AU  - Loo RO
AU  - Robicsek S
AU  - Ellingson BM
AU  - Gornbein J
AU  - Van Meter TE
AU  - Shaw G
AU  - Loo JA
AU  - Vespa PM
PY  - 2026
JO  - Acta neuropathologica communications
DO  - 10.1186/s40478-026-02240-y
UR  - https://doi.org/10.1186/s40478-026-02240-y
ER  -

APA

IB, W., J, H., J, L., S, S., Y, C., H, Z., C, S., RO, L., S, R., BM, E., J, G., TE, V. M., G, S., JA, L., & PM, V. (2026). GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.. Acta neuropathologica communications. https://doi.org/10.1186/s40478-026-02240-y

Source records

pubmed · retrieved 2026-09-26T02:15:37.845Z